glp 1 agonist wegovy for the Treatment of Chronic Weight Management, US GLP-1 Drugs: Ozempic, Wegovy, Semaglutide
Description
Check your GLP-1 receptor gene variants linked to weight loss response
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss
No direct causal link has been established between GLP-1R use and increased aspiration risk
Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide
Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins
The results of a Phase II clinical trial have demonstrated significant weight reduction in overweight and obese adults
